Jeffrey H. Cooper
2011 - BioMarin Pharmaceutical
In 2011, Jeffrey H. Cooper earned a total compensation of $2.8M as Senior Vice President, Chief Financial Officer at BioMarin Pharmaceutical, a 103% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $125,813 |
|---|---|
| Option Awards | $777,600 |
| Salary | $374,919 |
| Stock Awards | $1,503,075 |
| Other | $9,183 |
| Total | $2,790,590 |
Cooper received $1.5M in stock awards, accounting for 54% of the total pay in 2011.
Cooper also received $125.8K in non-equity incentive plan, $777.6K in option awards, $374.9K in salary and $9.2K in other compensation.
Rankings
In 2011, Jeffrey H. Cooper's compensation ranked 2,325th out of 10,747 executives tracked by ExecPay. In other words, Cooper earned more than 78.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,325 out of 10,747 | 78th |
Division Manufacturing | 833 out of 3,960 | 79th |
Major group Chemicals And Allied Products | 178 out of 1,033 | 83rd |
Industry group Drugs | 101 out of 781 | 87th |
Industry Pharmaceutical Preparations | 84 out of 571 | 85th |
Source: SEC filing on March 23, 2012.
Cooper's colleagues
We found four more compensation records of executives who worked with Jeffrey H. Cooper at BioMarin Pharmaceutical in 2011.
2011
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
2011
Henry Fuchs
BioMarin Pharmaceutical
Chief Medical Officer
2011
Stephen Aselage
BioMarin Pharmaceutical
Executive Vice President & Chief Business Officer
2011
Robert Baffi
BioMarin Pharmaceutical